Evidence map›Paper›PMID 23698709›Full record

ArticleGenes and immunity2013

The combination of two Sle2 lupus-susceptibility loci and Cdkn2c deficiency leads to T-cell-mediated pathology in B6.Fas(lpr) mice.

Z Xu, B P Croker, L Morel

Open access · bronzeAbstract read
In one paragraph

Article in Genes and immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Z XuDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610-0275, USA.
B P Croker
L Morel
University of Florida · US

Funding

Genetic dissection of Sle2 contribution to SLE pathogenesisR01AI068965 · NIAID · UNIVERSITY OF FLORIDA · PI MOREL, LAURENCE · 2006 to 2010
$1.7M
Genetic and Functional Analysis of IL-2 Deficiency in Lupus-Prone MiceK01AR056725 · NIAMS · UNIVERSITY OF FLORIDA · PI XU, ZHIWEI · 2009 to 2013
$531k
NIAID NIH HHS R01 AI068965NIAID NIH HHS R01-AI-068965NIAMS NIH HHS K01 AR056725NIAMS NIH HHS K01-AR-056725-01
6 · The paper itself

Abstract

The NZM2410 Sle2c1 lupus susceptibility locus is responsible for the expansion of the B1a cell compartment, and for the induction of T-cell induced renal and skin pathology on a CD95-deficient (Fas(lpr)) background. We have previously shown that deficiency in the cyclin-dependent kinase inhibitor p18(INK4c) (p18) was responsible for the B1a cell expansion but was not sufficient to account for the pathology in B6.lpr mice. This study was designed to map the additional Sle2c1 loci responsible for autoimmune pathology when co-expressed with CD95 deficiency. The production, fine-mapping and phenotypic characterization of five recombinant intervals indicated that three interacting subloci were responsive for inducting autoimmune pathogenesis in B6.lpr mice. One of these subloci corresponds most likely to p18 deficiency. Another major locus mapping to a 2-Mb region at the telomeric end of Sle2c1 is necessary to both renal and skin pathology. Finally, a third locus centromeric to p18 enhances the severity of lupus nephritis. These results provide new insights into the genetic interactions leading to systemic lupus erythematosus disease presentation, and represent a major step towards the identification of novel susceptibility genes involved in T-cell-mediated organ damage.

Indexed as

Genetic LociAnimalsChromosome MappingCyclin-Dependent Kinase Inhibitor p18Epistasis, Geneticfas ReceptorGenetic Predisposition to DiseaseKidneyLupus Erythematosus, SystemicMiceSkinT-Lymphocyte SubsetsCdkn2c protein, mouseCyclin-Dependent Kinase Inhibitor p18Fas protein, mousefas Receptor

Identifiers

PMID23698709
PMCPMC3752316
OpenAlexW1994689748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.